Over 1.45 crore vaccine doses available with states: Centre
India | Jun 26, 2021, 11:51 AM ISTMore than 1.45 crore COVID-19 vaccine doses are still available with states and union territories and over 19,10,650 jabs are in the pipeline.
More than 1.45 crore COVID-19 vaccine doses are still available with states and union territories and over 19,10,650 jabs are in the pipeline.
Vaccines Covishield and Covaxin work against SARS-CoV-2 variants Alpha, Beta, Gamma and Delta, while effectiveness tests against the Delta Plus variant is ongoing, the government said on Friday.
As per WHO guidelines, Emergency Use Listing (EUL) is a procedure to streamline the process by which new or unlicensed products can be used during public health emergencies. It has already submitted 90 per cent of documents to WHO for obtaining EUL for Covaxin
The Gurugram health department has announced a price cap for the administration of Covid-19 vaccines in private hospitals.
India on Tuesday administered around 53 lakh doses of Covid-19 vaccines. This is a nearly 40 per cent drop from Monday’s record-breaking 88 lakh inoculations.
Hyderabad-based Bharat Biotech has been facing tough questions over the delay in announcing its phase 3 trial data of the vaccine.
The Union Health Ministry has said that over 85.15 lakh vaccine doses, the highest in a single day, were administered across the country on Monday.
The United States has announced a plan to share 55 million of the 80 million Covid-19 vaccine doses promised to the world by President Joe Biden.
Bharat Biotech's Covaxin is one of the three vaccines which are currently being used in India. The phase III data of its vaccine have been questioned various times and that is what makes the data crucial which will ascertain the efficacy of the vaccine.
With Delhi receiving fresh stock of 1,67,000 Covishield doses for people in the 18-44 age group, the total number of Covid vaccines available for the group has now gone up to 2,95,000, senior AAP leader and MLA Atishi said on Saturday.
Bharat Biotech had said last month that it expects approval for its COVID-19 vaccine Covaxin from the World Health Organisation for Emergency Use Listing (EUL) during July-September.
Newborn calf serum is used only for the preparation and growth of vero cells. Serum from bovine and other animal are standard enrichment ingredient used globally for vero cell growth, the Union Health Ministry said in a statement
The Sputnik V vaccine was accorded emergency use authorization by the Drugs Controller General of India
The supply price of Bharat Biotech''s COVID-19 vaccine Covaxin to the central government at Rs 150 per dose is not sustainable in the long run, the vaccine maker said on Tuesday.
Congress leader Rahul Gandhi on Tuesday urged everyone to follow safety rules and get vaccinated saying no one is safe till the time everyone is.
The recruitment for the clinical trial Bharat Biotech's vaccine Covaxin, among children in the age group of 6-12 years will begin at the AIIMS today.
Delhi's All India Institute of Medical Sciences (AIIMS) is expected to begin on Tuesday the recruitment and clinical trials of India's first indigenously developed Covid-19 vaccine, Bharat Biotech's Covaxin, on children.
Bharat Biotech on Saturday said scientific standards and commitment of the indigenously-developed COVID-19 vaccine Covaxin are transparent.
In a setback to Bharat Biotech's COVID-19 vaccine Covaxin, the US Food and Drug Administration has "recommended" Ocugen Inc, the US partner of the Indian vaccine maker, to go for Biologics Licence Application (BLA) route with additional data, nixinghopes of Emergency Use Authorisation.
Bharat Biotech's application for approval of indigenous COVID-19 vaccine, Covaxin, has been rejected by the US FDA that cited a lack of sufficient data.
Top News
Latest News